The global apheresis market was valued at $2,560.4 million in 2016, and is expected to reach $4,200.6 million by 2023, registering a CAGR of 7.3% from 2017 to 2023. Apheresis procedures involve separation of desired components from the blood, while the remaining is either returned to the donor or the patient.
Use of large-scale plasma donations in the treatment of trauma patients, burn victims, and patients suffering from serious illness or injuries primarily contributes towards the growth of the apheresis market. In addition, rise in prevalence of cancer and surge in number of patients undergoing surgery have increased the number of plateletpheresis across the globe, thereby supplementing the market growth. However, dearth of skilled professionals and post-procedural complications associated with apheresis are anticipated to hamper the market growth. On the contrary, advancements in the healthcare sector in emerging economies are expected to offer significant profitable opportunities for the market players.
The global apheresis market is segmented based on product, method, procedure, component, end user, and region. On the basis of product, the market is classified into devices, disposable & reagents, and software. By method, it is categorized into centrifugation, membrane separation, and selective adsorption. Depending on procedure, it is divided into donor/automated apheresis and therapeutic apheresis. According to component, it is fragmented into plasma (plasmapheresis), platelets (plateletpheresis), leukocytes (leukapheresis), lymphocytes (lymph apheresis), and RBCS (erythropheresis). The end users covered in the study include blood centers, hospitals, and others. Regionally, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS
KEY MARKET SEGMENTS
By Product
By Method
By Procedure
By Component
By End User
By Region
KEY MARKET PLAYERS
The other players in the value chain include (profiles not included in the report)
Use of large-scale plasma donations in the treatment of trauma patients, burn victims, and patients suffering from serious illness or injuries primarily contributes towards the growth of the apheresis market. In addition, rise in prevalence of cancer and surge in number of patients undergoing surgery have increased the number of plateletpheresis across the globe, thereby supplementing the market growth. However, dearth of skilled professionals and post-procedural complications associated with apheresis are anticipated to hamper the market growth. On the contrary, advancements in the healthcare sector in emerging economies are expected to offer significant profitable opportunities for the market players.
The global apheresis market is segmented based on product, method, procedure, component, end user, and region. On the basis of product, the market is classified into devices, disposable & reagents, and software. By method, it is categorized into centrifugation, membrane separation, and selective adsorption. Depending on procedure, it is divided into donor/automated apheresis and therapeutic apheresis. According to component, it is fragmented into plasma (plasmapheresis), platelets (plateletpheresis), leukocytes (leukapheresis), lymphocytes (lymph apheresis), and RBCS (erythropheresis). The end users covered in the study include blood centers, hospitals, and others. Regionally, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS
- The study provides an in-depth analysis of the global apheresis market with the current trends and future estimations to elucidate the imminent investment pockets.
- Comprehensive analysis of the factors that drive and restrict the market growth is provided.
- Comprehensive quantitative analysis of the industry is provided from 2016 to 2023 to assist stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the key segments of the industry helps to understand the trends in apheresis globally.
- Key players and their strategies are provided to understand the competitive outlook of the industry.
KEY MARKET SEGMENTS
By Product
- Devices
- Disposable & Reagents
- Software
By Method
- Centrifugation
- Intermittent Flow Centrifugation
- Continuous Flow Centrifugation
- Membrane Separation
- Selective Adsorption
By Procedure
- Donor/Automated Apheresis
- Therapeutic Apheresis
- Type
- Plasma Exchange
- Stem Cell Harvest
- Photopheresis
- Low Density Lipid Removal
- Other Procedures
- Application
- Hematology
- Neurology
- Oncology
- Others
By Component
- Plasma (Plasmapheresis)
- Platelets (Plateletpheresis)
- Leukocytes (Leukapheresis)
- Lymphocytes (Lymph Apheresis)
- RBCs (Erythropheresis)
By End User
- Blood Centers
- Hospitals
- Other End Users
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- France
- Germany
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Turkey
- Saudi Arabia
- Rest of LAMEA
KEY MARKET PLAYERS
- Haemonetics Corporation
- Fresenius Kabi
- Terumo BCT, Inc.
- Asahi Kasei Medical Co., Ltd.
- HemaCare Corporation
- Kaneka Corporation
- Kawasumi Laboratories Inc.
- Cerus Corporation
- B. Braun Melsungen AG
- Nikkiso Co., Ltd.
The other players in the value chain include (profiles not included in the report)
- Grifols International SA
- Baxter International Inc.
- CSL Behring
- Immucor
- Becton, Dickinson & Co.
- Abbott Laboratories
- Medicap
- Bioelettronica
Frequently Asked Questions about the Global Apheresis Market
What is the estimated value of the Global Apheresis Market?
What is the growth rate of the Global Apheresis Market?
What is the forecasted size of the Global Apheresis Market?
Note: Product cover images may vary from those shown
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: APHERESIS MARKET BY PRODUCT
CHAPTER 5: APHERESIS MARKET BY PROCEDURE
CHAPTER 6: APHERESIS MARKET BY METHOD
CHAPTER 7: APHERESIS MARKET BY COMPONENT
CHAPTER 8: APHERESIS MARKET BY END USER
CHAPTER 9: APHERESIS MARKET BY REGION
CHAPTER 10: COMPANY PROFILE
Note: Product cover images may vary from those shown
LOADING...
According to a new report titled, Apheresis Market by Product, Method, Procedure, Component, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023, the global apheresis market was valued at $2,560.4 million in 2016, and is projected to reach $4,200.6 million by 2023, growing at a CAGR of 7.3% from 2017 to 2023. The disposable & reagents segment accounted for four-ninths of the total market share in 2016.
Apheresis system assists in the collection and separation of blood components for donation. In addition, this system can perform removal or exchange of blood components for therapeutic procedures. The American National Red Cross offers various therapeutic apheresis services across the U.S. that include plasmapheresis, photopheresis, LDL apheresis, and stem cell harvest. In addition, the center has employed qualified and specialized staff for apheresis procedures while maintaining the accessibility and availability regarding the same. Increase in the number of such blood centers across the globe significantly drives the growth of the apheresis market.
In addition, rise in government initiatives that promote blood donations in the developing countries such as China and India propels the market growth. For instance, Twitter has recently launched a social initiative called BloodMatters in India on March 2018. Twitter has collaborated with the voluntary blood donation helpline named Blood Donors. Moreover, increase in number of blood donations was observed in China in 2014, which led to increase in the number of blood centers in the country. Such circumstances positively impact the market growth.
The centrifugation method generated the highest revenue in 2016, and is expected to maintain this dominance throughout the forecast period. This is attributed to the fact that centrifugation is considered to be a standard method for apheresis, and is highly favored by the blood industry across the globe. However, the membrane separation segment is expected to register the highest growth rate during the forecast period, owing to rise in demand for membrane separation apheresis, as it prevents the need for replacement fluids by not depleting the blood coagulation factors.
Based on procedure, the market is divided into donor/automated apheresis and therapeutic apheresis. Donor/automated apheresis is anticipated to dominate the global market throughout the forecast period, due to increase in gap between blood supply and blood products, which facilitate the need for using apheresis machines. Moreover, rise in apheresis procedures across several specialties such as hematology, neurology, and oncology has contributed towards the robust growth displayed by this segment. The therapeutic apheresis is expected to grow at the highest rate from 2017 to 2023.
Key findings of the Apheresis Market:
The platelets (plateletpheresis) segment is expected to register the highest growth rate from 2017 to 2023.
Blood centers accounted for maximum revenue in 2016, and is anticipated to maintain this trend throughout the forecast period.
North America dominated the global apheresis market, accounting for maximum share in 2016, and is expected to retain the same trend during the forecast period.
Intermittent flow centrifugation segment dominated the centrifugation apheresis market in 2016 and is expected to maintain this trend during the forecast period.
Photopheresis is estimated to exhibit the highest CAGR of 9.3% from 2017 to 2023 in the therapeutic apheresis market.
Asia-Pacific is expected to witness the highest growth rate throughout the forecast period, due to its high population base, upsurge in disposable income, and rise in patient awareness towards blood donation. In addition, increase in incidence of dengue across countries in the Asia-Pacific region is the key contributor for the market growth in the region.
The major companies profiled in this report include Haemonetics Corporation, Fresenius Kabi, Terumo BCT, Inc., Asahi Kasei Medical Co., Ltd., HemaCare Corporation, Kaneka Corporation, Kawasumi Laboratories Inc., Cerus Corporation, B. Braun Melsungen AG, and Nikkiso Co., Ltd. Other prominent players in the value chain include Grifols International SA, Baxter International Inc., CSL Behring, Immucor, Becton, Dickinson & Co., Abbott Laboratories, Medicap, and Bioelettronica.
Apheresis system assists in the collection and separation of blood components for donation. In addition, this system can perform removal or exchange of blood components for therapeutic procedures. The American National Red Cross offers various therapeutic apheresis services across the U.S. that include plasmapheresis, photopheresis, LDL apheresis, and stem cell harvest. In addition, the center has employed qualified and specialized staff for apheresis procedures while maintaining the accessibility and availability regarding the same. Increase in the number of such blood centers across the globe significantly drives the growth of the apheresis market.
In addition, rise in government initiatives that promote blood donations in the developing countries such as China and India propels the market growth. For instance, Twitter has recently launched a social initiative called BloodMatters in India on March 2018. Twitter has collaborated with the voluntary blood donation helpline named Blood Donors. Moreover, increase in number of blood donations was observed in China in 2014, which led to increase in the number of blood centers in the country. Such circumstances positively impact the market growth.
The centrifugation method generated the highest revenue in 2016, and is expected to maintain this dominance throughout the forecast period. This is attributed to the fact that centrifugation is considered to be a standard method for apheresis, and is highly favored by the blood industry across the globe. However, the membrane separation segment is expected to register the highest growth rate during the forecast period, owing to rise in demand for membrane separation apheresis, as it prevents the need for replacement fluids by not depleting the blood coagulation factors.
Based on procedure, the market is divided into donor/automated apheresis and therapeutic apheresis. Donor/automated apheresis is anticipated to dominate the global market throughout the forecast period, due to increase in gap between blood supply and blood products, which facilitate the need for using apheresis machines. Moreover, rise in apheresis procedures across several specialties such as hematology, neurology, and oncology has contributed towards the robust growth displayed by this segment. The therapeutic apheresis is expected to grow at the highest rate from 2017 to 2023.
Key findings of the Apheresis Market:
The platelets (plateletpheresis) segment is expected to register the highest growth rate from 2017 to 2023.
Blood centers accounted for maximum revenue in 2016, and is anticipated to maintain this trend throughout the forecast period.
North America dominated the global apheresis market, accounting for maximum share in 2016, and is expected to retain the same trend during the forecast period.
Intermittent flow centrifugation segment dominated the centrifugation apheresis market in 2016 and is expected to maintain this trend during the forecast period.
Photopheresis is estimated to exhibit the highest CAGR of 9.3% from 2017 to 2023 in the therapeutic apheresis market.
Asia-Pacific is expected to witness the highest growth rate throughout the forecast period, due to its high population base, upsurge in disposable income, and rise in patient awareness towards blood donation. In addition, increase in incidence of dengue across countries in the Asia-Pacific region is the key contributor for the market growth in the region.
The major companies profiled in this report include Haemonetics Corporation, Fresenius Kabi, Terumo BCT, Inc., Asahi Kasei Medical Co., Ltd., HemaCare Corporation, Kaneka Corporation, Kawasumi Laboratories Inc., Cerus Corporation, B. Braun Melsungen AG, and Nikkiso Co., Ltd. Other prominent players in the value chain include Grifols International SA, Baxter International Inc., CSL Behring, Immucor, Becton, Dickinson & Co., Abbott Laboratories, Medicap, and Bioelettronica.
Note: Product cover images may vary from those shown
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
